Contact
Please use this form to send email to PR contact of this press release:
Pulmonary Arterial Hypertension (PAH) Market Projected to Reach $8.7 Billion by 2025 - Key Players are Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corp, GlaxoSmithKline, and Pfizer
TO: